As on Wednesday, Agios Pharmaceuticals Inc (NASDAQ: AGIO) started slowly as it slid -50.89% to $22.34, before settling in for the price of $45.49 at the close. Taking a more long-term approach, AGIO posted a 52-week range of $23.42-$62.45.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -160.29%. This publicly-traded company’s shares outstanding now amounts to $58.28 million, simultaneously with a float of $55.11 million. The organization now has a market capitalization sitting at $1.30 billion. At the time of writing, stock’s 50-day Moving Average stood at $40.38, while the 200-day Moving Average is $35.13.
Agios Pharmaceuticals Inc (AGIO) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Agios Pharmaceuticals Inc’s current insider ownership accounts for 5.49%, in contrast to 108.41% institutional ownership. According to the most recent insider trade that took place on Nov 12 ’25, this organization’s Director sold 200 shares at the rate of 43.84, making the entire transaction reach 8,768 in total value, affecting insider ownership by 17,603. Preceding that transaction, on Nov 11 ’25, Company’s Chief Medical Officer sold 2,454 for 43.78, making the whole transaction’s value amount to 107,436. This particular insider is now the holder of 61,727 in total.
Agios Pharmaceuticals Inc (AGIO) Earnings and Revenue Records
Agios Pharmaceuticals Inc’s EPS decrease for this current 12-month fiscal period is -160.29% and is forecasted to reach -6.98 in the upcoming year.
Agios Pharmaceuticals Inc (NASDAQ: AGIO) Trading Performance Indicators
Let’s observe the current performance indicators for Agios Pharmaceuticals Inc (AGIO). It’s Quick Ratio in the last reported quarter now stands at 13.39. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 29.09.
In the same vein, AGIO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -6.96, a figure that is expected to reach -1.93 in the next quarter, and analysts are predicting that it will be -6.98 at the market close of one year from today.
Technical Analysis of Agios Pharmaceuticals Inc (AGIO)
Through scrutinizing the latest numbers posted by the [Agios Pharmaceuticals Inc, AGIO], it can be observed that its last 5-days Average volume of 4.13 million was better the volume of 0.77 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 60.14% While, its Average True Range was 16.32.
Raw Stochastic average of Agios Pharmaceuticals Inc (AGIO) in the period of the previous 100 days is set at 0.42%, which indicates a major rise in contrast to 0.42% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 2.09 that was higher than 1.75 volatility it exhibited in the past 100-days period.
